JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2016, Vol. 30 ›› Issue (4): 101-104.doi: 10.6040/j.issn.1673-3770.0.2015.481

Previous Articles     Next Articles

Changes of ocular hemodynamics after intravitreal ranibizumab injection in patients with wet age-related macular degeneration.

ZHAO Lu, XIE Guoli, WANG Yanling   

  1. Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
  • Received:2015-11-12 Online:2016-08-16 Published:2016-08-16

Abstract: Objective To evaluate the changes in retrobulbar blood flow by using color Doppler sonography in patients who had undergone a single intravitreal ranibizumab injection for wet age-related macular degeneration(wAMD). Methods 20 wAMD patients(20 eyes)who had undergone intravitreal 0.5 mg ranibizumab injection were enrolled in this study. The ophthalmic artery, central retinal artery and ciliary artery of both eyes of patients were evaluated by color Doppler sonography. Peak systolic velocity(PSV), end-diastolic velocity(EDV), and resistance index(RI)and pulsatility index(PI)values were calculated before injection, and after injection on day 7 and day 30. The differences of ocular hemodynamic parameters were analysed at different time points. Results In a comparison with the pre-injection values of PSV, EDV, RI and PI, the post-injection values at both 1 and 4 week showed no statistically significant difference in ophthalmic artery, central retinal artery and lateral posterior ciliary artery. Similarly, all the same parameters revealed no statistically significant difference in the un-injected healthy fellow eyes. Conclusion Intravitreal ranibizumab injection for wAMD does not cause a significant difference in the retrobulbar blood flow in either the injected eye or the fellow eye.

Key words: Ranibizumab, Retrobulbar blood flow, Wet age-related macular degeneration

CLC Number: 

  • R774.5
[1] Furino C, Boscia F, Cardascia N, et al. Hemorrhagic macular infarction after intravitreal bevacizumab for central retinal vein occlusion[J]. Ophthalmic Surg Lasers Imaging, 2010, 9(1):1-2.
[2] Ganssauge M, Wilhelm H, Bartz-Schmidt K U, et al. Non-arteritic anterior ischemic optic neuropathy(NA-AION)after intravitreal injection of bevacizumab(Avastin_)for treatment of angoid streaks in pseudoxanthoma elasticum[J]. GraefesArch Clin Exp Ophthalmol, 2009, 247(12):1707-1710.
[3] Huang Z L, Lin K H, Lee Y C, et al. Acute vision loss after intravitreal injection of bevacizumab(avastin)associated with ocular ischemic syndrome[J]. Ophthalmologica, 2010, 224(2):86-89.
[4] Mansour A M, Bynoe L A, Welch J C, et al. Retinal vascular events after intravitreal bevacizumab[J]. Acta Ophthalmol, 2010, 88(7):730-735.
[5] Schmidt-Erfurth U. Clinical safety of ranibizumab in age-reIated macular degeneration[J]. Expert Opin Drug Saf, 2010, 9(1):149-165.
[6] Dimitrova G, Tamaki Y, Kato S. Retrobulbar circulation in patients with age-related maculopathy[J]. Eye, 2002, 16(5):580-586.
[7] Dimitrova G, Kato S. Color Doppler imaging of retinal diseases[J]. Surv Ophthalmol, 2010, 55(3):193-214.
[8] Friedman E, Krupsky S, Lane A M, et al. Ocular blood flow velocity in age-related macular degeneration[J]. Ophthalmology, 1995, 102(4):640.
[9] 李惠荣,李惠玲,吴秀荣,等.彩色多普勒超声对年龄相关性黄斑变性患者眼血流动力学的评价[J].山东医药, 2009, 49(41):84-85.
[10] Hosseini H, Lotfi M, Esfahani M H, et al.Effect of intravitreal bevacizumab on retrobulbar blood flow in njected and uninjected fellow eyes of patients with neovascular age-related macular degeneration[J]. Retina, 2012, 32(5):967-971.
[11] Toklu Y, Cakmak H B, Raza S, et al. Short-term effects of intravitreal bevacizumab(Avastin(®))on retrobulbar hemodynamics in patients with neovascular age-related macular degeneration[J]. Acta Ophthalmol, 2011, 89(1):e41-45.
[12] Yuksel K, Altinkaynak H, Kina A, et al. Can intravitreal ranibizumab alter retrobulbar circulation in eye with age- related macular degeneration?[J]. J Ocul Pharmacol Ther, 2013, 29(8):723-727.
[13] Sakalar Y B, Senturk S, Yildirim M, et al. Evaluation of retrobulbar blood flow by color doppler ultrasonography after intravitreal ranibizumab injection in patients with neovascular age-related macular degeneration[J]. J Clin Ultrasound, 2013, 41(1):32-37.
[14] Zhu Q, Ziemssen F, Henke-Fahle S, et al. Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization[J]. Ophthalmology, 2008, 115(10):1750-1755.
[1] ZHOU Xueyi, LI Yiming, WANG Meiju, ZHANG Yuanyuan, ZHANG Lizhuo. The application of 25-gauge minimally invasive vitreoretinal surgery combined with intravitreal ranibizumab injections in the treatment of proliferative diabetic retinopathy. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 87-89.
[2] WANG Cui, YAN Xin, ZHAO Bojun. Combination of intravitreal ranibizumab with photodynamic therapy in the treatment of wet age-related macular degeneration. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 94-97.
[3] . Clinical observation on the treatment of CSME and NCSME by intravitreal injection of ranibizumab. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(2): 96-98.
[4] . Clinical observation on the treatment of BRVO-ME by the combination of laser therapy with Ranibizumab intravitreal injection. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(1): 110-113.
[5] CHAI Xuerong, ZHANG Shixi, TAO Yu, SHEN Jiaquan. Effect of intravitreal ranibizumab injection combined with trabelectomy and panretinal photocoagulation for neovascular glaucoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(3): 72-75.
[6] ZI Yu-meng1, WANG Yu2, FAN Chuan-feng2, SHU Xiang-wen2, WU Chang-long2. Intravitreal injection of Ranibizumab for idiopathic choroidal neovascularization lesion in two courses [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(3): 63-66.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] WANG Xiao-ye, YOU Jian-qiang, QIU Jian-he. Quality of life in patients under care of sublingual immunotherapy[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(3): 13 -15 .
[2] ZHU Wenyan, JIN Xin, SHE Wandong, MA Yongchi. Assessment of psychopathological characteristics in 30 patients with sudden sensorineural hearing loss[J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(5): 50 -52 .
[3] ZHOU Hui, HUANG Xue-qin, HU Jun-li, YAO Jun, ZHANG Yue-fei, JIANG Feng. Experimental study on Scutellarin influence DEX in the process of chemotherapy for nasopharyngeal carcinoma[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(4): 30 -32 .
[4] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2007, 21(3): 266 -266 .
[5] SU Faren, DING Jinghua, LIU Xingang, BO Lin. Bone-anchored hearing aids softband implanted in patients with bilateral congenital microtia.[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(1): 74 -75 .
[6] TAO Yu, ZHANG Shi-xi, CHAI Xue-rong, SHEN Jia-quan. Clinical study on glaucoma patients’ quality of life and related factors[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(2): 84 -86 .
[7] LIANG Song-min1, GUO Yong-wei2, ZHAO Xia1. The diagnostic effectiveness of  portable monitors device  in obstructive sleep apnea hypopnea syndrome[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(2): 22 -25 .
[8] JIANG Chao-yong, CAI Yong-ming, YIN Ya-lei. Clinical trial of postaurical drug injection to treat sudden hearing loss[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(6): 18 -20 .
[9] PANG Wen-hui1, SHI Guang-gang1, SHI Lei1, WANG He-feng2, WANG Xiao-ting1, HAN Jie1, LI Jian-feng1, WANG Hai-bo1. Experimental study on regulatory T cells and IgE, IL-4 and IL-5 in a mouse model of allergic rhinitis and in administration of nasal corticosteroid[J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(2): 29 -33 .
[10] LI Xiao-jing, LIU Huai-gang. Sevoflurane inhalation anesthesia with laryngeal mask spontaneous ventilation in ptosis surgery[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(5): 72 -73 .